These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 12424733
1. Role of c-Jun concentration in neuronal cell death. Rössler OG, Steinmüller L, Giehl KM, Thiel G. J Neurosci Res; 2002 Dec 01; 70(5):655-64. PubMed ID: 12424733 [Abstract] [Full Text] [Related]
2. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells. Eriksson M, Taskinen M, Leppä S. J Cell Physiol; 2007 Feb 01; 210(2):538-48. PubMed ID: 17111371 [Abstract] [Full Text] [Related]
3. Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells. Leppä S, Eriksson M, Saffrich R, Ansorge W, Bohmann D. Mol Cell Biol; 2001 Jul 01; 21(13):4369-78. PubMed ID: 11390664 [Abstract] [Full Text] [Related]
4. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines. Crowe DL, Brown TN, Kim R, Smith SM, Lee MK. Mol Cell Biol Res Commun; 2000 Apr 01; 3(4):243-8. PubMed ID: 10891399 [Abstract] [Full Text] [Related]
5. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells. Adams DS, Hasson B, Boyer-Boiteau A, El-Khishin A, Shashoua VE. J Neurosci Res; 2003 May 01; 72(3):405-16. PubMed ID: 12692907 [Abstract] [Full Text] [Related]
6. Kainic acid-induced excitotoxicity is associated with a complex c-Fos and c-Jun response which does not preclude either cell death or survival. Pozas E, Ballabriga J, Planas AM, Ferrer I. J Neurobiol; 1997 Sep 01; 33(3):232-46. PubMed ID: 9298762 [Abstract] [Full Text] [Related]
7. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor. Kim S, Brown PH, Birrer MJ. Oncogene; 1996 Mar 07; 12(5):1043-53. PubMed ID: 8649795 [Abstract] [Full Text] [Related]
8. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Dosch J, Kaina B. Oncogene; 1996 Nov 07; 13(9):1927-35. PubMed ID: 8934539 [Abstract] [Full Text] [Related]
9. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells]. Chuĭkin IA, Lianguzova MS, Pospelov VA. Tsitologiia; 2004 Nov 07; 46(12):1080-90. PubMed ID: 15747838 [Abstract] [Full Text] [Related]
10. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Echlin DR, Tae HJ, Mitin N, Taparowsky EJ. Oncogene; 2000 Mar 30; 19(14):1752-63. PubMed ID: 10777209 [Abstract] [Full Text] [Related]
11. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes. Tay DL, Hoffbrand AV, Wickremasinghe GR. Exp Hematol; 1996 Feb 30; 24(2):277-84. PubMed ID: 8641353 [Abstract] [Full Text] [Related]
12. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Bossis G, Malnou CE, Farras R, Andermarcher E, Hipskind R, Rodriguez M, Schmidt D, Muller S, Jariel-Encontre I, Piechaczyk M. Mol Cell Biol; 2005 Aug 30; 25(16):6964-79. PubMed ID: 16055710 [Abstract] [Full Text] [Related]
13. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction. Eckhoff DE, Smyth CA, Eckstein C, Bilbao G, Young CJ, Thompson JA, Contreras JL. Surgery; 2003 Aug 30; 134(2):169-79. PubMed ID: 12947315 [Abstract] [Full Text] [Related]
14. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression. Aubert N, Falluel-Morel A, Vaudry D, Xifro X, Rodriguez-Alvarez J, Fisch C, de Jouffrey S, Lebigot JF, Fournier A, Vaudry H, Gonzalez BJ. J Neurochem; 2006 Nov 30; 99(4):1237-50. PubMed ID: 17026529 [Abstract] [Full Text] [Related]
15. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation. Nadori F, Lardeux B, Rahmani M, Bringuier A, Durand-Schneider AM, Bernuau D. Hepatology; 1997 Dec 30; 26(6):1477-83. PubMed ID: 9397987 [Abstract] [Full Text] [Related]
16. Mechanism of action of a dominant-negative mutant of c-Jun. Brown PH, Chen TK, Birrer MJ. Oncogene; 1994 Mar 30; 9(3):791-9. PubMed ID: 8108121 [Abstract] [Full Text] [Related]
17. In vivo anergized CD4+ T cells have defective expression and function of the activating protein-1 transcription factor. Sundstedt A, Dohlsten M. J Immunol; 1998 Dec 01; 161(11):5930-6. PubMed ID: 9834073 [Abstract] [Full Text] [Related]
18. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Zhong CY, Zhou YM, Douglas GC, Witschi H, Pinkerton KE. Carcinogenesis; 2005 Dec 01; 26(12):2187-95. PubMed ID: 16051644 [Abstract] [Full Text] [Related]
19. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity. Hilfiker-Kleiner D, Hilfiker A, Castellazzi M, Wollert KC, Trautwein C, Schunkert H, Drexler H. Cardiovasc Res; 2006 Jul 01; 71(1):108-17. PubMed ID: 16690042 [Abstract] [Full Text] [Related]
20. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells. Pang M, Martinez AF, Fernandez I, Balkan W, Troen BR. Gene; 2007 Nov 15; 403(1-2):151-8. PubMed ID: 17897792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]